Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of consolidated pneumonia in children younger than 5 years old in Pilar, Buenos Aires: A population-based study | Zendy

Ricardo Gutiérrez | Zendy; Buenos Aires | Zendy; Federico Hospital Pediátrico | Zendy; P. Néstor Falcón | Zendy; J.L. Tirado Hospital | Zendy; Pilar Sanguinetti | Zendy; Ángela Gentile | Zendy; Julia Bakir | Zendy; Laura Bialorus | Zendy; Laura Caruso | Zendy; Diego Mirra | Zendy; Celina Santander | Zendy; Mabel Terluk | Zendy; Pablo Zurdo | Zendy; Fernando Gentile | Zendy; M. Isabel Fernández | Zendy

Open Access

Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of consolidated pneumonia in children younger than 5 years old in Pilar, Buenos Aires: A population-based study

Author(s) -

Ricardo Gutiérrez,

Buenos Aires,

Federico Hospital Pediátrico,

P. Néstor Falcón,

J.L. Tirado Hospital,

Pilar Sanguinetti,

Ángela Gentile,

Julia Bakir,

Laura Bialorus,

Laura Caruso,

Diego Mirra,

Celina Santander,

Mabel Terluk,

Pablo Zurdo,

Fernando Gentile,

M. Isabel Fernández

Publication year - 2015

Publication title -

archivos argentinos de pediatria

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.236

H-Index - 19

eISSN - 1668-3501

pISSN - 0325-0075

DOI - 10.5546/aap.2015.eng.502

Subject(s) - medicine , incidence (geometry) , pneumonia , pneumococcal conjugate vaccine , pediatrics , pneumococcal pneumonia , population , streptococcus pneumoniae , environmental health , microbiology and biotechnology , antibiotics , physics , optics , biology

In January 2012, Argentina introduced the 13-valent pneumococcal conjugate vaccine (PCV13) in its immunization schedule for children younger than 2 years old. Coverage in Pilar in 2012 reached>90% for the first two doses and 60% for the third dose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research